[SY1] シンポジウム1「認知症治療薬の最新動向」

[SY1-5] Phosphorylated Tau Targeted Passive & Active Immunotherapy in Alzheimer’s Disease

^○Lennert Steukers¹, Ziad Saad², Gallen Triana-Baltzer² (1.Janssen Pharmaceutica NV, a Johnson & Johnson company Beerse, Belgium, 2.Janssen Research & Development LLC, a Johnson & Johnson company La Jolla, USA, 3.Janssen Research & Development LLC, a Johnson & Johnson company Titusville, USA)